BIOMAT Database Logo BIOMAT Database Logo

[Bioavailability of furosemide in humans]. 1978

L Wichliński, and J Maruchin, and B Wiezowska

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

L Wichliński, and J Maruchin, and B Wiezowska
Comparative bioavailability of two furosemide formulations in humans.
April 1984, Journal of pharmaceutical sciences,
L Wichliński, and J Maruchin, and B Wiezowska
[Bioavailability of furosemide in right cardiac insufficiency].
April 1995, Deutsche medizinische Wochenschrift (1946),
L Wichliński, and J Maruchin, and B Wiezowska
Pharmacokinetics and bioavailability of furosemide in sheep.
July 2021, Journal of veterinary pharmacology and therapeutics,
L Wichliński, and J Maruchin, and B Wiezowska
Bioavailability study of furosemide prodrugs in rats.
September 1992, Farmaco (Societa chimica italiana : 1989),
L Wichliński, and J Maruchin, and B Wiezowska
Bioavailability of seven furosemide tablets in man.
January 1986, Biopharmaceutics & drug disposition,
L Wichliński, and J Maruchin, and B Wiezowska
Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
April 1990, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
L Wichliński, and J Maruchin, and B Wiezowska
Polymeric microcontainers improve oral bioavailability of furosemide.
May 2016, International journal of pharmaceutics,
L Wichliński, and J Maruchin, and B Wiezowska
Implications of intraindividual variability in bioavailability studies of furosemide.
January 1984, European journal of clinical pharmacology,
L Wichliński, and J Maruchin, and B Wiezowska
Cloprednol bioavailability in humans.
July 1978, Journal of pharmaceutical sciences,
L Wichliński, and J Maruchin, and B Wiezowska
Yohimbine bioavailability in humans.
January 1990, European journal of clinical pharmacology,
Copied contents to your clipboard!